Greece · Delayed Price · Currency is EUR Unibios Holdings Statistics
Total Valuation
ATH:BIOSK has a market cap or net worth of EUR 41.63 million. The enterprise value is 48.18 million.
| Market Cap | 41.63M |
| Enterprise Value | 48.18M |
Important Dates
The next estimated earnings date is Friday, June 26, 2026.
| Earnings Date | Jun 26, 2026 |
| Ex-Dividend Date | Oct 9, 2025 |
Share Statistics
ATH:BIOSK has 17.20 million shares outstanding. The number of shares has increased by 15.05% in one year.
| Current Share Class | 17.20M |
| Shares Outstanding | 17.20M |
| Shares Change (YoY) | +15.05% |
| Shares Change (QoQ) | +26.14% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 28.17.
| PE Ratio | 28.17 |
| Forward PE | n/a |
| PS Ratio | 3.00 |
| PB Ratio | 1.96 |
| P/TBV Ratio | 4.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 76.24 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 28.86 |
| EV / Sales | 3.47 |
| EV / EBITDA | 24.30 |
| EV / EBIT | 34.77 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.48.
| Current Ratio | 1.91 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 5.16 |
| Debt / FCF | -6.38 |
| Interest Coverage | 4.12 |
Financial Efficiency
Return on equity (ROE) is 7.71% and return on invested capital (ROIC) is 3.68%.
| Return on Equity (ROE) | 7.71% |
| Return on Assets (ROA) | 2.63% |
| Return on Invested Capital (ROIC) | 3.68% |
| Return on Capital Employed (ROCE) | 5.25% |
| Weighted Average Cost of Capital (WACC) | 5.30% |
| Revenue Per Employee | 128,615 |
| Profits Per Employee | 15,460 |
| Employee Count | 108 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, ATH:BIOSK has paid 732,856 in taxes.
| Income Tax | 732,856 |
| Effective Tax Rate | 32.93% |
Stock Price Statistics
The stock price has increased by +18.63% in the last 52 weeks. The beta is 0.33, so ATH:BIOSK's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +18.63% |
| 50-Day Moving Average | 2.60 |
| 200-Day Moving Average | 2.76 |
| Relative Strength Index (RSI) | 35.55 |
| Average Volume (20 Days) | 19,471 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ATH:BIOSK had revenue of EUR 13.89 million and earned 1.67 million in profits. Earnings per share was 0.09.
| Revenue | 13.89M |
| Gross Profit | 5.91M |
| Operating Income | 1.39M |
| Pretax Income | 2.23M |
| Net Income | 1.67M |
| EBITDA | 1.81M |
| EBIT | 1.39M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 6.28 million in cash and 10.24 million in debt, with a net cash position of -3.96 million or -0.23 per share.
| Cash & Cash Equivalents | 6.28M |
| Total Debt | 10.24M |
| Net Cash | -3.96M |
| Net Cash Per Share | -0.23 |
| Equity (Book Value) | 21.27M |
| Book Value Per Share | 1.11 |
| Working Capital | 9.42M |
Cash Flow
In the last 12 months, operating cash flow was 546,051 and capital expenditures -2.15 million, giving a free cash flow of -1.60 million.
| Operating Cash Flow | 546,051 |
| Capital Expenditures | -2.15M |
| Depreciation & Amortization | 428,019 |
| Net Borrowing | 1.31M |
| Free Cash Flow | -1.60M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 42.51%, with operating and profit margins of 9.97% and 12.02%.
| Gross Margin | 42.51% |
| Operating Margin | 9.97% |
| Pretax Margin | 16.02% |
| Profit Margin | 12.02% |
| EBITDA Margin | 13.06% |
| EBIT Margin | 9.97% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 1.03%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 1.03% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | -15.05% |
| Shareholder Yield | -14.03% |
| Earnings Yield | 4.01% |
| FCF Yield | -3.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 10, 2017. It was a reverse split with a ratio of 0.2.
| Last Split Date | Feb 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
ATH:BIOSK has an Altman Z-Score of 2.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.6 |
| Piotroski F-Score | 4 |